2008
DOI: 10.1080/17482960802378998
|View full text |Cite
|
Sign up to set email alerts
|

Web-based data management for a phase II clinical trial in ALS

Abstract: The objective was to report on the creation, features and performance of a web-based data management system for a two-stage phase II randomized clinical trial of Co-Enzyme Q10 in ALS. We created a relatively comprehensive web-based data system that provided electronic data entry; patient management utilities; adverse event reporting, safety monitoring, and invoice generation; and standardized coding for medications and adverse events. In stage 1, clinical sites submitted 7207 forms reporting on 105 patients fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Our solution differs from other systems, which only manage and organize patient treatment 10, 11 and other numerous approaches only documenting a single clinical study electronically. [12][13][14][15] Up to today, it is complex and time-consuming to run clinical studies with a large patient group and a multicenter structure, because of the amount and heterogeneity of data as well as the different ways of documenting in different formats within participating institutions. Especially in the field of radiation oncology, one must deal with distributed data in various information systems.…”
Section: Discussionmentioning
confidence: 99%
“…Our solution differs from other systems, which only manage and organize patient treatment 10, 11 and other numerous approaches only documenting a single clinical study electronically. [12][13][14][15] Up to today, it is complex and time-consuming to run clinical studies with a large patient group and a multicenter structure, because of the amount and heterogeneity of data as well as the different ways of documenting in different formats within participating institutions. Especially in the field of radiation oncology, one must deal with distributed data in various information systems.…”
Section: Discussionmentioning
confidence: 99%